Appetite-suppressing GLP-1 medications may be changing the way Canadians eat – Smaller appetites and healthier choices are impacting restaurants and the food supply sector in significant ways.
With over eight million Canadians living with obesity and only four weight loss medications that aren’t made to treat diabetes, Wegovy is in high demand.
Mounjaro®, an injectable prescription medicine that is used to improve blood sugar (glucose) in adults with type 2 diabetes is now available in Canada.